8X6B
Crystal structure of immune receptor PVRIG in complex with ligand Nectin-2
Summary for 8X6B
| Entry DOI | 10.2210/pdb8x6b/pdb |
| Descriptor | Transmembrane protein PVRIG, Nectin-2, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... (4 entities in total) |
| Functional Keywords | complex, immune system |
| Biological source | Homo sapiens (human) More |
| Total number of polymer chains | 2 |
| Total formula weight | 28771.39 |
| Authors | |
| Primary citation | Hu, S.,Han, P.,Wang, M.,Cao, X.,Liu, H.,Zhang, S.,Zhang, S.,Liu, J.,Han, Y.,Xiao, J.,Chen, Q.,Miao, K.,Qi, J.,Tan, S.,Gao, G.F.,Wang, H. Structural basis for the immune recognition and selectivity of the immune receptor PVRIG for ligand Nectin-2. Structure, 32:918-929.e4, 2024 Cited by PubMed Abstract: Nectin and nectin-like (Necl) co-receptor axis, comprised of receptors DNAM-1, TIGIT, CD96, PVRIG, and nectin/Necl ligands, is gaining prominence in immuno-oncology. Within this axis, the inhibitory receptor PVRIG recognizes Nectin-2 with high affinity, but the underlying molecular basis remains unknown. By determining the crystal structure of PVRIG in complex with Nectin-2, we identified a unique CC' loop in PVRIG, which complements the double-lock-and-key binding mode and contributes to its high affinity for Nectin-2. The association of the corresponding charged residues in the F-strands explains the ligand selectivity of PVRIG toward Nectin-2 but not for Necl-5. Moreover, comprehensive comparisons of the binding capacities between co-receptors and ligands provide innovative insights into the intra-axis immunoregulatory mechanism. Taken together, these findings broaden our understanding of immune recognition and regulation mediated by nectin/Necl co-receptors and provide a rationale for the development of immunotherapeutic strategies targeting the nectin/Necl axis. PubMed: 38626767DOI: 10.1016/j.str.2024.03.012 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2 Å) |
Structure validation
Download full validation report






